Overview

Latin America Next Generation Sequencing Market is poised to value over CAGR of over 14.1% during the forecast period 2022 to 2028

FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Latin America Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Latin America Next Generation Sequencing Market:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Pacific Biosciences of California, Inc.
• Qiagen N.V.
• Oxford Nanopore Technologies Ltd
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• PerkinElmer, Inc.
• F. Hoffmann-La Roche AG
• 10x Genomics, Inc. .
• Macrogen Inc.
• Partek Inc.
• Agilent Technologies Inc.
• Genomatix Software GmbH
• GATC Biotech Ag
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Latin America Next Generation Sequencing Market Segmentation:
By Type
• Consumables
 o Sample Preparation Consumables
   o DNA Fragmentation & Amplification
   o Library Preparation & Target Enrichment
   o Quality Control
 o Other Consumables
• NGS Platforms/Instruments
 o Illumina NGS Platforms/Instruments
 o Thermo Fisher Scientific NGS Platforms/Instruments
 o Pacific Biosciences NGS Platforms/Instruments
 o Oxford Nanopore NGS Platforms/Instruments
 o Others
• Software
• Services

By Sequencing Type
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing
• Others

By Technology
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Single-Molecule Real-Time Sequencing
• Nanopore Sequencing
• Others

By Application
• Clinical Application
 o Oncology
 o Reproductive Health Diagnostics
   o Non-Invasive Pre-natal Testing
   o Carrier Screening
   o In-Vitro fertilization
   o Newborn Screening
 o Cardiovascular
 o Others
• Research Application
 o Drug Discovery
 o Agriculture & Animal Research
 o Others

By End user
• Clinical Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

By Region
• Brazil
• Venezuela
• Argentina
• Rest of Latin America

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Latin America Next Generation Sequencing Market By Type, By Sequencing Type, By Technology, By Application, By End user and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Latin America Next Generation Sequencing Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Latin America Next Generation Sequencing Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Latin America Next Generation Sequencing Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Latin America Next Generation Sequencing Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Consumables
       7.1.1. Sample Preparation Consumables
              7.1.1.1. DNA Fragmentation & Amplification
              7.1.1.2. Library Preparation & Target Enrichment
              7.1.1.3. Quality Control
       7.1.2. Other Consumables
  7.2. NGS Platforms/Instruments
       7.2.1. Illumina NGS Platforms/Instruments
       7.2.2. Thermo Fisher Scientific NGS Platforms/Instruments
       7.2.3. Pacific Biosciences NGS Platforms/Instruments
       7.2.4. Oxford Nanopore NGS Platforms/Instruments
       7.2.5. Others
  7.3. Software
  7.4. Services

8. Latin America Next Generation Sequencing Market, By Sequencing Type Historical Analysis and Forecast 2022-2028 (USD Million)
  8.1. Whole Genome Sequencing
  8.2. Whole Exome Sequencing
  8.3. Targeted Sequencing
  8.4. Others

9. Latin America Next Generation Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)
  9.1. Sequencing by Synthesis
  9.2. Ion Semiconductor Sequencing
  9.3. Sequencing by Ligation
  9.4. Single-Molecule Real-Time Sequencing
  9.5. Nanopore Sequencing
  9.6. Others

10. Latin America Next Generation Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
  10.1. Clinical Application
        10.1.1. Oncology
        10.1.2. Reproductive Health Diagnostics
                10.1.2.1. Non-Invasive Pre-natal Testing
                10.1.2.2. Carrier Screening
                10.1.2.3. In-Vitro fertilization
                10.1.2.4. Newborn Screening
        10.1.3. Cardiovascular
        10.1.4. Others
  10.2. Research Application
        10.2.1. Drug Discovery
        10.2.2. Agriculture & Animal Research
        10.2.3. Others

11. Latin America Next Generation Sequencing Market, By End user Historical Analysis and Forecast 2022-2028 (USD Million)
  11.1. Clinical Diagnostic Laboratories
  11.2. Pharmaceutical & Biotechnology Companies
  11.3. Academic & Research Institutes
  11.4. Others

12. Latin America Next Generation Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. Brazil
         12.2.2. Venezuela
         12.2.3. Argentina
         12.2.4. Rest of Latin America
   12.3. Market Size (USD Million) Forecast for Latin America 2022-2028

13. Market Share Analysis and Competitive Landscape  
   13.1. Latin America Landscape - Key Players, Revenue and Presence
   13.2. Latin America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   13.3. Latin America Emerging Companies
   13.4. Latin America - Market Share Analysis and Key Regional Players
   13.5. Latin America Key Player - Growth Matrix

14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   14.1. Illumina, Inc.
         14.1.1. Company Overview
         14.1.2. Product Portfolio
         14.1.3. SWOT Analysis
         14.1.4. Financial Overview
         14.1.5. Strategic Overview
   14.2. Thermo Fisher Scientific Inc.
         14.2.1. Company Overview
         14.2.2. Product Portfolio
         14.2.3. SWOT Analysis
         14.2.4. Financial Overview
         14.2.5. Strategic Overview
   14.3. Pacific Biosciences of California, Inc.
         14.3.1. Company Overview
         14.3.2. Product Portfolio
         14.3.3. SWOT Analysis
         14.3.4. Financial Overview
         14.3.5. Strategic Overview
   14.4. Qiagen N.V.
         14.4.1. Company Overview
         14.4.2. Product Portfolio
         14.4.3. SWOT Analysis
         14.4.4. Financial Overview
         14.4.5. Strategic Overview
   14.5. Oxford Nanopore Technologies Ltd
         14.5.1. Company Overview
         14.5.2. Product Portfolio
         14.5.3. SWOT Analysis
         14.5.4. Financial Overview
         14.5.5. Strategic Overview          
   14.6. Bio-Rad Laboratories, Inc.
         14.6.1. Company Overview
         14.6.2. Product Portfolio
         14.6.3. SWOT Analysis
         14.6.4. Financial Overview
         14.6.5. Strategic Overview      
   14.7. Beckman Coulter, Inc.
         14.7.1. Company Overview
         14.7.2. Product Portfolio
         14.7.3. SWOT Analysis
         14.7.4. Financial Overview
         14.7.5. Strategic Overview
   14.8. PerkinElmer, Inc.
         14.8.1. Company Overview
         14.8.2. Product Portfolio
         14.8.3. SWOT Analysis
         14.8.4. Financial Overview
         14.8.5. Strategic Overview
   14.9. F. Hoffmann-La Roche AG
         14.9.1. Company Overview
         14.9.2. Product Portfolio
         14.9.3. SWOT Analysis
         14.9.4. Financial Overview
         14.9.5. Strategic Overview
   14.10.10x Genomics, Inc. .
         14.10.1. Company Overview
         14.10.2. Product Portfolio
         14.10.3. SWOT Analysis
         14.10.4. Financial Overview
         14.10.5. Strategic Overview
   14.11.Macrogen Inc.
         14.11.1. Company Overview
         14.11.2. Product Portfolio
         14.11.3. SWOT Analysis
         14.11.4. Financial Overview
         14.11.5. Strategic Overview
   14.12.Partek Inc.
         14.12.1. Company Overview
         14.12.2. Product Portfolio
         14.12.3. SWOT Analysis
         14.12.4. Financial Overview
         14.12.5. Strategic Overview
   14.13.Agilent Technologies Inc.
         14.13.1. Company Overview
         14.13.2. Product Portfolio
         14.13.3. SWOT Analysis
         14.13.4. Financial Overview
         14.13.5. Strategic Overview
   14.14.Genomatix Software GmbH
         14.14.1. Company Overview
         14.14.2. Product Portfolio
         14.14.3. SWOT Analysis
         14.14.4. Financial Overview
         14.14.5. Strategic Overview
   14.15 GATC Biotech Ag
         14.15.1. Company Overview
         14.15.2. Product Portfolio
         14.15.3. SWOT Analysis
         14.15.4. Financial Overview
         14.15.5. Strategic Overview                  

15. Pre and Post COVID-19 Impact
   15.1. Positive influence on the healthcare industry
   15.2. The financial disruption of the manufacturing sector
   15.3. Impact of COVID-19 on emerging companies
   15.4. Significant mandates in the healthcare regulations initiated by administrations
   15.5. The overall economic slowdown of the developing and developed nations

16. FutureWise SME Key Takeaway Points for Client

Tables

Figures